Trending News
News
News
How C. difficile Toxins enter Cells
Clostridium difficile is a dangerous intestinal bacterium that can cause severe diarrhoea and life-threatening intestinal infections after long-term treatment with antibiotics.
News
Designing New Pain Relief Drugs
Researchers have identified the molecular interactions that allow capsaicin to activate the body’s primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain.
News
Dalton Pharma Forms Manufacturing Agreement with Andes Biotechnologies
Dalton Pharma Services has signed a new service contract with Andes Biotechnologies to supply large molecule sterile dose manufacturing services for their Phase I/II clinical trials.
News
Improving HIV Vaccines
Researchers have identified a protein that could improve the body’s immune response to HIV vaccines and prevent transmission of the virus.
News
Galapagos DARWIN 1 and 2 Studies have Completed 24 Weeks of Treatment
Topline results from final analyses expected to be released in July and August 2015.
News
Vetter Development Service Chicago Completes Recent On-Site Expansion Activities
Continued demand and increased customer product transfers are generating a positive business outlook for the company’s early-stage development facility.
News
Engineers Crack DNA Code of Autoimmune Disorders
Researchers have identified an unexpectedly general set of rules that determine which molecules can cause the immune system to become vulnerable to the autoimmune disorders lupus and psoriasis.
News
Gecko-Inspired Adhesives for Microfluidics
Scientists from Canada report an affordable manufacturing advance in microfluidics with a dry adhesive system that demonstrates strong, self-healing and reversible bonding.
News
One-Drop-of-Blood Reveals a Patient’s Viral History
New technology developed by Howard Hughes Medical Institute researchers makes it possible to test for current and past infections with any known human virus by analyzing a single drop of a person's blood.
News
NCI-MATCH Trial will Link Targeted Cancer Drugs to Gene Abnormalities
Precision medicine trial will open to patient enrollment in July.
Advertisement